SG11201602614XA - Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines - Google Patents

Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Info

Publication number
SG11201602614XA
SG11201602614XA SG11201602614XA SG11201602614XA SG11201602614XA SG 11201602614X A SG11201602614X A SG 11201602614XA SG 11201602614X A SG11201602614X A SG 11201602614XA SG 11201602614X A SG11201602614X A SG 11201602614XA SG 11201602614X A SG11201602614X A SG 11201602614XA
Authority
SG
Singapore
Prior art keywords
difluorotetrahydrouridines
deoxy
synthetic route
route
synthetic
Prior art date
Application number
SG11201602614XA
Other languages
English (en)
Inventor
Hyeong-Wook Choi
Steven Mathieu
Frank Fang
Bryan Matthew Lewis
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SG11201602614XA publication Critical patent/SG11201602614XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201Oxygen-containing compounds
    • B01J31/0209Esters of carboxylic or carbonic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0237Amines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0244Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
SG11201602614XA 2013-10-29 2014-10-29 Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines SG11201602614XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361896703P 2013-10-29 2013-10-29
PCT/US2014/062874 WO2015066162A1 (en) 2013-10-29 2014-10-29 Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Publications (1)

Publication Number Publication Date
SG11201602614XA true SG11201602614XA (en) 2016-05-30

Family

ID=51982743

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602614XA SG11201602614XA (en) 2013-10-29 2014-10-29 Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Country Status (20)

Country Link
US (3) US9834576B2 (pt)
EP (1) EP3063164B1 (pt)
JP (1) JP6427567B2 (pt)
KR (1) KR102272773B1 (pt)
CN (1) CN105683209B (pt)
AU (1) AU2014342402B2 (pt)
BR (1) BR112016008855B1 (pt)
CA (1) CA2926734C (pt)
ES (1) ES2712877T3 (pt)
HK (1) HK1223627A1 (pt)
IL (1) IL244849B (pt)
MX (1) MX363205B (pt)
MY (1) MY176465A (pt)
NZ (1) NZ718607A (pt)
PH (1) PH12016500683A1 (pt)
RU (1) RU2681939C2 (pt)
SA (1) SA516371019B1 (pt)
SG (1) SG11201602614XA (pt)
WO (1) WO2015066162A1 (pt)
ZA (1) ZA201602315B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016008855B1 (pt) 2013-10-29 2023-01-17 Otsuka Pharmaceutical Co., Ltd 2-desóxi-2,2-difluourotetra-hidrouridinas, e seus métodos de produção
US11224610B2 (en) 2018-09-19 2022-01-18 Otsuka Pharmaceutical Co., Ltd. Low dose combination CDA substrate drug/cedazuridine with extended administration
AU2020363412A1 (en) * 2019-10-08 2022-04-07 Otsuka Pharmaceutical Co., Ltd. 2'-deoxy-2',2'-difluorotetrahydrouridines with high purity and methods of making the same
CN113402573B (zh) * 2020-07-31 2023-06-20 集美大学 一种鞣质类化合物及其提取方法和应用
WO2022254457A1 (en) * 2021-05-29 2022-12-08 Msn Laboratories Private Limited, R&D Center An improved process for the preparation of (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-4-hydroxy-1,3-diazinan-2one and its intermediate compounds
US20230271996A1 (en) * 2021-12-25 2023-08-31 Scinopharm Taiwan, Ltd. Process for preparing cedazuridine
TWI821074B (zh) * 2021-12-25 2023-11-01 台灣神隆股份有限公司 製備希達路里定(cedazuridine)的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US5223608A (en) 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
FR2682112B1 (fr) 1991-10-08 1993-12-10 Commissariat A Energie Atomique Procede de synthese d'acide ribonucleique (arn) utilisant un nouveau reactif de deprotection.
US5371210A (en) 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5521294A (en) 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
US6001994A (en) 1995-12-13 1999-12-14 Eli Lilly And Company Process for making gemcitabine hydrochloride
CA2241255A1 (en) 1995-12-22 1997-07-03 East Carolina University Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
US5760208A (en) 1996-08-14 1998-06-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Process to prepare pyrimidine nucleosides
US7125983B2 (en) 2000-11-29 2006-10-24 Mitsui Chemicals, Inc. L-nucleic acid derivatives and process for the synthesis thereof
FI112640B (fi) 2000-12-22 2003-12-31 Kone Corp Hissin turvalaite
KR101108407B1 (ko) * 2006-06-21 2012-01-30 일라이 릴리 앤드 캄파니 젬시타빈 아미드 전구약물의 결정 형태, 그의 조성물 및 용도
JO2778B1 (en) * 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
BR112016008855B1 (pt) 2013-10-29 2023-01-17 Otsuka Pharmaceutical Co., Ltd 2-desóxi-2,2-difluourotetra-hidrouridinas, e seus métodos de produção

Also Published As

Publication number Publication date
BR112016008855B1 (pt) 2023-01-17
IL244849A0 (en) 2016-05-31
PH12016500683B1 (en) 2016-05-30
US11028119B2 (en) 2021-06-08
RU2016115523A3 (pt) 2018-06-05
KR102272773B1 (ko) 2021-07-02
HK1223627A1 (zh) 2017-08-04
US20180072768A1 (en) 2018-03-15
AU2014342402B2 (en) 2018-11-01
CN105683209B (zh) 2019-03-08
RU2681939C2 (ru) 2019-03-14
RU2016115523A (ru) 2017-12-04
MY176465A (en) 2020-08-11
BR112016008855A2 (pt) 2017-08-01
CA2926734C (en) 2022-03-15
PH12016500683A1 (en) 2016-05-30
EP3063164B1 (en) 2018-12-05
MX363205B (es) 2019-03-13
CA2926734A1 (en) 2015-05-07
US20200123189A1 (en) 2020-04-23
CN105683209A (zh) 2016-06-15
WO2015066162A1 (en) 2015-05-07
SA516371019B1 (ar) 2018-01-23
US20160237107A1 (en) 2016-08-18
EP3063164A1 (en) 2016-09-07
AU2014342402A1 (en) 2016-04-21
ES2712877T3 (es) 2019-05-16
NZ718607A (en) 2019-10-25
MX2016005596A (es) 2016-12-09
US10526362B2 (en) 2020-01-07
KR20160083021A (ko) 2016-07-11
JP6427567B2 (ja) 2018-11-21
US9834576B2 (en) 2017-12-05
JP2017500281A (ja) 2017-01-05
ZA201602315B (en) 2019-07-31
IL244849B (en) 2019-10-31

Similar Documents

Publication Publication Date Title
HK1220468A1 (zh) 的人抗體
ZA201602315B (en) Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines
PT2970339T (pt) 1-hidroxibenzo-oxaboroles como agentes antiparasíticos
EP2990028A4 (en) THICKENING COMPOSITION
HK1220456A1 (zh) -乙酰嗎啡類似物,和其合成方法和用途
GB2516706B (en) Railway points
GB201312513D0 (en) 2 4 1 Technology
GB201321597D0 (en) Clip'n'Chill
GB201322203D0 (en) Deens' merger
AU5094P (en) Eggben 008 Salvia hybrid
AU5233P (en) Eggben 009 Salvia hybrid
GB201322287D0 (en) Inside - out trolley
GB201322568D0 (en) Taggstar 1
GB201310407D0 (en) Plantladders 3
GB201309694D0 (en) Artist's implement
GB201311540D0 (en) Concept 72
GB201311488D0 (en) Concept 51
GB201311525D0 (en) Concept 43
GB201311542D0 (en) Concept 70
GB201311538D0 (en) Concept 21
GB201311491D0 (en) Concept 54
GB201311536D0 (en) Concept 73
GB201311469D0 (en) Concept 12 12
GB201311499D0 (en) Concept 7
GB201311489D0 (en) Concept 52